SC 13G
NONE
- Company
- Scinai Immunotherapeutics Ltd.
- Filed
- October 6, 2022
- Accession Number
- 0001567619-22-018298
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →